Search Results - "Ramadan, Nadire"
-
1
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
Published in Proceedings of the National Academy of Sciences - PNAS (25-02-2014)“…Defects in epigenetic regulation play a fundamental role in the development of cancer, and epigenetic regulators have recently emerged as promising therapeutic…”
Get full text
Journal Article -
2
ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
Published in eLife (16-05-2016)“…The TMPRSS2:ERG gene fusion is common in androgen receptor (AR) positive prostate cancers, yet its function remains poorly understood. From a screen for…”
Get full text
Journal Article -
3
Design and implementation of high-throughput RNAi screens in cultured Drosophila cells
Published in Nature protocols (01-09-2007)“…This protocol describes the various steps and considerations involved in planning and carrying out RNA interference (RNAi) genome-wide screens in cultured…”
Get full text
Journal Article -
4
Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells
Published in Scientific reports (16-02-2017)“…Chemogenomic profiling is a powerful and unbiased approach to elucidate pharmacological targets and the mechanism of bioactive compounds. Until recently,…”
Get full text
Journal Article -
5
TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer
Published in Cell reports (Cambridge) (30-10-2018)“…Perturbed epigenomic programs play key roles in tumorigenesis, and chromatin modulators are candidate therapeutic targets in various human cancer types. To…”
Get full text
Journal Article -
6
FlyRNAi: the Drosophila RNAi screening center database
Published in Nucleic acids research (01-01-2006)“…RNA interference (RNAi) has become a powerful tool for genetic screening in DROSOPHILA: At the Drosophila RNAi Screening Center (DRSC), we are using a library…”
Get full text
Journal Article -
7
Abstract PR06: A functional screen of the epigenome identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
Published in Molecular cancer therapeutics (01-11-2013)“…Abstract Epigenetic dysregulation is an emerging hallmark of cancers, and the identification of recurrent somatic mutations in chromatin regulators implies a…”
Get full text
Journal Article